Armata Pharmaceuticals Inc (ARMP) Price

eXoZymes Reports Major Biomanufacturing Scale-Up

eXoZymes Inc. announced a successful 100-fold scale-up of its proprietary biomanufacturing process for the molecule NCT, achieving over 99% conversion efficiency. The news triggered a significant positive market reaction, with the company's stock gaining over 14% on elevated trading volume.